Search results for "Keeping tabs"


 
Results 91 - 100 of about 151 for "Keeping tabs".

October 11, 2013 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

June 14, 2013 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Spotlight on HIV and diabetes | ACP Diabetes Monthly

Multiple recent studies focused on HIV and diabetes, looking at incidence of diabetes among patients with HIV, the effectiveness of medications in patients with both conditions, and efforts to improve nutrition in patients with one or both

January 12, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

October 12, 2012 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

July 13, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

April 13, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Spotlight on genetic risk for diabetes | ACP Diabetes Monthly

Recent studies looked at biomarkers to predict diabetes, characteristics of patients who developed type 1 diabetes during adulthood, and use of oral insulin to try to prevent type 1 diabetes.

Spotlight on cardiovascular disease | ACP Diabetes Monthly

The American Heart Association and American Diabetes Association recently released a joint scientific statement on prevention of cardiovascular disease in adults with type 2 diabetes.

Spotlight on insulins degludec and glargine | ACP Diabetes Monthly

Recent industry-funded studies compared degludec, an ultralong-acting, once-daily basal insulin, to basal insulin glargine on outcomes including hypoglycemia, glucose control, and cardiovascular events.

Result Page: Prev   5   6   7   8   9   10   11   12   13   14   Next